Trial Profile
FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jan 2024
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Insulin aspart; Insulin glargine; Insulin glulisine; Insulin lispro; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms FLAT-SUGAR
- 22 Dec 2023 Double blind added to design term.
- 09 Jun 2015 Primary endpoint 'Glucose level (coefficient of variation of continuous glucose readings)' has been met as reported by abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.